Amparo Estepa Selected Research

Amparo Estepa Research Topics

Disease

21	Infections 04/2017 - 06/2005
7	Viral Hemorrhagic Septicemia 01/2017 - 08/2004
4	Virus Diseases (Viral Diseases) 01/2017 - 03/2013
4	Hemorrhagic Septicemia (Haemorrhagic Septicemia) 11/2015 - 09/2010
2	Superinfection 04/2017 - 11/2016
2	Viremia 11/2015 - 09/2014
2	Necrosis 02/2015 - 01/2013
1	Premature Aging 10/2019
1	Inflammation (Inflammations) 01/2017
1	Hemorrhage 11/2015
1	Vesicular Stomatitis 09/2014
1	Persistent Infection 10/2013
1	Carcinoma (Carcinomatosis) 10/2013

Drug/Important Bio-Agent (IBA)

11	Antiviral Agents (Antivirals)IBA 04/2017 - 06/2005
5	Glycoproteins (Glycoprotein)IBA 09/2014 - 06/2011
4	RNA (Ribonucleic Acid)IBA 04/2017 - 08/2004
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2010
3	VaccinesIBA 01/2016 - 09/2010
2	Protein Isoforms (Isoforms)IBA 01/2017 - 07/2013
2	erucylphosphocholineIBA 11/2016 - 10/2013
2	Poly I-CIBA 01/2016 - 09/2008
2	Transcription Factors (Transcription Factor)IBA 02/2015 - 01/2013
2	DNA VaccinesIBA 01/2014 - 01/2013
2	guanylyl-(3'-5')-guanosineIBA 01/2013 - 06/2011
1	AntioxidantsIBA 10/2019
1	Acetylcarnitine (Alcar)IBA 10/2019
1	navitoclaxIBA 10/2019
1	InterferonsIBA 01/2017
1	FicollIBA 01/2017
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	CytokinesIBA 01/2016
1	tiplaxtininIBA 11/2015
1	Tannic Acid FDA Link 11/2015
1	Peptides (Polypeptides)IBA 11/2015
1	SerpinsIBA 11/2015
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 11/2015
1	InterleukinsIBA 02/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2015
1	Activating Transcription Factor 1IBA 02/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2015
1	Mitogen-Activated Protein KinasesIBA 01/2015
1	Epidermal Growth Factor (EGF)IBA 01/2015
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 06/2014
1	Liposomes (Liposome)IBA 06/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	Neutralizing AntibodiesIBA 11/2013
1	Immunoglobulin M (IgM)IBA 03/2013
1	AntibodiesIBA 03/2013
1	Monoclonal AntibodiesIBA 02/2013
1	Melitten (Melittin)IBA 02/2013
1	Viral RNAIBA 01/2013
1	Conditioned Culture MediaIBA 04/2011
1	Histocompatibility Antigens Class IIBA 09/2010
1	Complement System Proteins (Complement)IBA 09/2010
1	Differentiation AntigensIBA 09/2010
1	Galectin 1 (LGALS1)IBA 11/2009
1	Recombinant ProteinsIBA 11/2009
1	Ribavirin (Virazole)FDA LinkGeneric 05/2007
1	olive leaf extractIBA 06/2005
1	Plant ExtractsIBA 06/2005
1	oleuropeinIBA 06/2005
1	Viral ProteinsIBA 06/2005

Therapy/Procedure

1	Therapeutics 01/2016